Cargando…
OPTIMISE: MS study protocol: a pragmatic, prospective observational study to address the need for, and challenges with, real world pharmacovigilance in multiple sclerosis
INTRODUCTION: The power of ‘real world’ data to improve our understanding of the clinical aspects of multiple sclerosis (MS) is starting to be realised. Disease modifying therapy (DMT) use across the UK is driven by national prescribing guidelines. As such, the UK provides an ideal country in which...
Autores principales: | Dobson, Ruth, Craner, Matthew, Waddingham, Ed, Miller, Aleisha, Cavey, Ana, Webb, Stewart, Hemingway, Cheryl, Hobart, Jeremy, Evangelou, Nikos, Scolding, Neil, Rog, David, Nicholas, Richard, Marta, Monica, Blain, Camilla, Young, Carolyn Anne, Ford, Helen L, Matthews, Paul M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627413/ https://www.ncbi.nlm.nih.gov/pubmed/34824113 http://dx.doi.org/10.1136/bmjopen-2021-050176 |
Ejemplares similares
-
Challenges and Opportunities of Real-World Data: Statistical Analysis Plan for the Optimise:MS Multicenter Prospective Cohort Pharmacovigilance Study
por: Waddingham, Ed, et al.
Publicado: (2022) -
The Patient’s Voice in Pharmacovigilance: Pragmatic Approaches to Building a Patient-Centric Drug Safety Organization
por: Smith, Meredith Y., et al.
Publicado: (2016) -
Why and how? Addressing to the two most pertinent questions about pharmacovigilance in Ayurveda
por: Rastogi, Sanjeev
Publicado: (2011) -
Addressing identification bias in the design and analysis of cluster-randomized pragmatic trials: a case study
por: Bobb, Jennifer F., et al.
Publicado: (2020) -
An Industry Survey on Managing the Pharmacovigilance System Master File in a Global Environment: The Need for a Pragmatic Approach
por: Lavery, Clare, et al.
Publicado: (2022)